Results 221 to 230 of about 23,559 (275)
An isoflavone-enriched diet alleviates Parkinson's disease in mice by inhibiting ferroptosis through gut microbiota-mediated serotonin production. [PDF]
Front ImmunolYang L, Ma Y, Wang H, Xie L, Yu Y.
europepmc +1 more source
Dietary Intake of Animal and Plant-Based Protein on Adiposity Measurements and Body Composition in Pre- and Postmenopausal Women: A Systematic Review of Randomized Clinical Trials. [PDF]
FASEB JFialho SN +4 more
europepmc +1 more source
Determination of Phenolic Content and Antioxidant Activity in Khabarovsk Soybean Cultivars. [PDF]
MoleculesKholodkov A +3 more
europepmc +1 more source
Gut microbiota-mediated biotransformation of dietary bioactive compounds: inter-individual variability, determinants, and implications for personalised nutrition. [PDF]
Front Syst BiolChakraborty T +3 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Journal of Heterocyclic Chemistry, 2004
AbstractFor Abstract see ChemInform Abstract in Full Text.
openaire +1 more source
AbstractFor Abstract see ChemInform Abstract in Full Text.
openaire +1 more source
Bioavailability of isoflavones
Journal of Chromatography B, 2002Isoflavones are disease protective components of soybeans. Isoflavone metabolism and bioavailability are key to understanding their biological effects. Isoflavone glucuronides, dominant biotransformation products in humans that are more hydrophilic than isoflavone aglycones, activate human natural killer cells in vitro but are less toxic to NK cells ...
openaire +2 more sources
Enzymic synthesis of isoflavones
European Journal of Biochemistry, 1986The NADPH and oxygen‐dependent conversion of (2S)‐naringenin to genistein catalyzed by a microsomal preparation from elicitor‐treated soybean cell suspension cultures has been resolved into two steps. In the first step (2S)‐naringenin is converted to a product (P‐2) which yields genistein in a second step.
G, Kochs, H, Grisebach
openaire +2 more sources
Isoflavones and cardiovascular disease
Maturitas, 2010The specific profile of estrogens on cardiovascular risk, with limiting action on atherogenesis but a less clear protection on cardiovascular episodes, might be improved by other agonists of the estrogen receptor, such as isoflavones. By using a systematic search based on the electronic Medline database plus a hand-search of reference lists of selected
Antonio, Cano +2 more
openaire +2 more sources
Soy, Isoflavones and Atherosclerosis
2005Consumption of soy protein is associated with a lower risk of cardiovascular disease in man, and reduced atherosclerosis in a variety of experimental animals. Although a portion of the cardiovascular protective effects appears to be due to reductions in plasma lipoprotein concentration, in most people the magnitude of this effect is relatively small ...
R St, Clair, M, Anthony
openaire +2 more sources
Journal of Chinese Integrative Medicine, 2003
Isoflavones as a kind of phytoestrogen exist in soy plant widely. With the advantages of estrogen, they can regulate endocrine function of the human body, reduce blood cholesterol, decrease the incidence of coronary heart disease, prevent osteoporosis, inhibit tumor growth, and relieve pain.
Ning, Du, Yong, Xu
openaire +2 more sources
Isoflavones as a kind of phytoestrogen exist in soy plant widely. With the advantages of estrogen, they can regulate endocrine function of the human body, reduce blood cholesterol, decrease the incidence of coronary heart disease, prevent osteoporosis, inhibit tumor growth, and relieve pain.
Ning, Du, Yong, Xu
openaire +2 more sources